— Revenue from the cannabis segment reached CAD2.81 million. The company started the commercial operations of its Cannabis segment in March 2019.
— Revenue from the nutraceutical segment declined by 3% to CAD6.34 million.
— The adjusted EBITDA loss widened from last year, due to the investments made in the cannabis segment to grow the workforce in anticipation of increased sales volume as well as higher salaries and benefits at the corporate level.
ADVERTISEMENT
— The company launched its hemp-derived wellness products, Forest Remedies and Ocean Remedies, in the US. A similar launch in Canada will be followed once approved by health authorities.